fluorogenic acetylated hdac substrate 3 (BPS Bioscience)
Structured Review
Fluorogenic Acetylated Hdac Substrate 3, supplied by BPS Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 44 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fluorogenic+substrate/Fluorogenic+HDAC+substrate+3/pm42966048-513-11-16
Average 94 stars, based on 44 article reviews
Images
Related Articles
other:Article Title: 3-(2-(heteroaryl)-pyridin-4-yl)-5-(trifluoromethyl)-1,2,4-oxadiazole derivatives as HDAC6 inhibitors Article Snippet: 2.5 μL of Incubation:Article Title: New Vanillyl-capped HDAC inhibitors exhibit anti-tumor efficacy in neuroblastoma and glioblastoma cells. Article Snippet: Histone deacetylases 6 and 8 (HDAC6/8) have emerged as promising therapeutic targets in aggressive neural tumors such as neuroblastoma and glioblastoma.. Herein, we report the design, synthesis, and comprehensive biological evaluation of a novel series of hydroxamic acid-based inhibitors (5a–p), featuring nature-inspired vanillyl CAP groups.. Structure–activity relationship (SAR) analysis, supported by molecular docking, elucidated the role of CAP, connecting unit, and linker structure, alongside zinc-binding group orientation, on isoform selectivity and potency. Article Title: Reversing TGF-β1-induced fibrotic phenotype in human lung fibroblasts using a PROTAC tool derived from an indoline-based HDAC6 inhibitor Article Snippet: For the evaluation of their inhibitory activity, different concentrations of the compounds were incubated in a low-binding black 96-well plate with 30 ng of human recombinant HDAC6 (BPS Bioscience, San Diego, CA, USA; Cat. # 50056), human recombinant HDAC1 (BPS Bioscience; Cat. # 50051), human recombinant HDAC8 (BPS Bioscience; Cat. # 50008), or 500 ng of human recombinant HDAC10 (BPS Bioscience; Cat. # 50060) in an assay buffer composed of 25 mM Tris/HCl, pH 8.0, 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl2, and 0.1 mg/mL bovine serum albumin for 30 min at 37 ◦C. .. At the end of the incubation, the deacetylation reaction was initiated by adding 200 μM of the Concentration Assay:Article Title: Supporting Information Design, Synthesis, Biological Evaluation, and Structural Characterization of Potent Histone Deacetylase Inhibitors Based on Cyclic α/β-Tetrapeptide Architectures Article Snippet: .. The appropriate dilution of the inhibitor (10 μL of a 5× concentration solution) was added to each well followed by HDAC assay buffer (25 μL), bovine serum albumin (5 μL, 1 mg/mL) and Histone Deacetylase Assay:Article Title: Supporting Information Design, Synthesis, Biological Evaluation, and Structural Characterization of Potent Histone Deacetylase Inhibitors Based on Cyclic α/β-Tetrapeptide Architectures Article Snippet: .. The appropriate dilution of the inhibitor (10 μL of a 5× concentration solution) was added to each well followed by HDAC assay buffer (25 μL), bovine serum albumin (5 μL, 1 mg/mL) and |

